NAD on Immune Nutrisoda
This article was originally published in The Tan Sheet
Executive Summary
PepsiAmericas subsidiary Ardea Beverages will discontinue a print advertisement for Immune Nutrisoda following a determination by the National Advertising Division that "the advertisement went beyond simple structure/function claims." The ad, which featured images of a can of the product and an airplane, stated "protection from seat 33b." Other claims in the ad included "Immune Nutrisoda doesn't just refresh you, it revitalizes you....It's full of the right stuff to help support your body's immune defenses." The images and statements in the spot "combine to convey a message that this product will do more than simply provide vitamins and minerals that will help to maintain a healthy immune system," NAD concludes in a Nov. 21 decision. Ardea "respectfully disagrees" with NAD's assessment, but says it will take the suggestions into consideration in planning future advertisements...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.